Limbach Holdings (LMB) Misses Q1 EPS by 22c, Revenues Miss; Offers FY21 Revenues Guidance Below Consensus

Go back to Limbach Holdings (LMB) Misses Q1 EPS by 22c, Revenues Miss; Offers FY21 Revenues Guidance Below Consensus
Holmes Biopharma, Inc. (NASDAQ: LMB) Delayed: 8.99 +0.07 (0.78%)
Previous Close $8.92    52 Week High $0.15 
Open $8.90    52 Week Low $0.15 
Day High $8.99    P/E N/A 
Day Low $8.87    EPS $0.00 
Volume 3,134